Company / Total Assets
Coherus Oncology, Inc. Total Assets History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$408.9M
FY2019
5-year range
$99.5M / $408.9M
FY2015-FY2019
Trend
+311.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets changed +311% YoY in FY2019, a notable deviation from the 5-year average annual change of +52%.
Based on SEC 10-K filings.
$409M in FY2019 with a 5-year CAGR of +16.9%.
Improved from $163M to $409M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +31.8%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2019, total assets increased 311.1% year-over-year.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $408.9M | +311.1% |
| FY2018 | $99.5M | -38.8% |
| FY2017 | $162.6M | -8.9% |
| FY2016 | $178.5M | -16.0% |
| FY2015 | $212.4M | +13.4% |
| FY2014 | $187.2M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026